Injeq Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

Injeq General Information

Description

Manufacturer of a bio-impedance measurement device designed to help in promoting efficiency in surgeries. The company's device specializes in the form of a needle that knows the physiological condition of organs and also performs tissue identification, enabling surgeons to perform high-precision surgeries with perfection and efficiency.

Contact Information

Website
www.injeq.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Biokatu 8
  • 33520 Tampere
  • Finland
+358 040
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Parent Company
Flat Medical
Vertical(s)
HealthTech
Corporate Office
  • Biokatu 8
  • 33520 Tampere
  • Finland
+358 040

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Injeq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 25-Sep-2024 Completed Generating Revenue
8. Later Stage VC 21-Apr-2022 Completed Generating Revenue
7. Later Stage VC 01-Jan-2021 Completed Generating Revenue
6. Equity Crowdfunding 18-Nov-2020 Completed Generating Revenue
5. Equity Crowdfunding 31-Jul-2019 Completed Generating Revenue
4. Debt - General 01-Jan-2017 Completed Generating Revenue
3. Grant 01-Jan-2017 Completed Generating Revenue
2. Later Stage VC 21-Dec-2016 $272K Completed Generating Revenue
1. Seed Round 29-Dec-2015 $272K $272K Completed Startup
To view Injeq’s complete valuation and funding history, request access »

Injeq Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 129,792 $2.28 $2.28 1x $2.28 2.87%
To view Injeq’s complete cap table history, request access »

Injeq Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of a bio-impedance measurement device designed to help in promoting efficiency in surgeries. The company's
Medical Supplies
Tampere, Finland
16 As of 2023

Wijnegem, Belgium
 

Nes Ziona, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Injeq Competitors (4)

One of Injeq’s 4 competitors is Novosanis, a Formerly VC-backed company based in Wijnegem, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novosanis Formerly VC-backed Wijnegem, Belgium
NanoPass Technologies Venture Capital-Backed Nes Ziona, Israel
Current Surgical Venture Capital-Backed Washington, DC
PharmaJet Venture Capital-Backed Golden, CO
To view Injeq’s complete competitors history, request access »

Injeq Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • Pending

  • Expiring in next 12 mo

Injeq Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3484373-B1 A biopsy gun, a biopsy sample collecting system and a method for connecting at least one needle electrode of a biopsy needle to a connector and/or to a measurement cable in a biopsy gun Active 16-Jul-2016
EP-3484373-A1 A biopsy gun, a biopsy needle, a biopsy sample collecting system and a method for connecting at least one needle electrode of a biopsy needle to a connector and/or to a measurement cable in a biopsy gun Active 16-Jul-2016
EP-3302290-A1 Biopsy needle for biopsy sampling, biopsy device, and methods of manufacturing a biopsy needle or a biopsy device Active 07-Jun-2015
EP-3302290-B1 Biopsy needle for biopsy sampling, biopsy device, and methods of manufacturing a biopsy needle or a biopsy device Active 07-Jun-2015
EP-3302290-B8 Biopsy needle for biopsy sampling, biopsy device, and methods of manufacturing a biopsy needle or a biopsy device Active 07-Jun-2015 A61B10/0275
To view Injeq’s complete patent history, request access »

Injeq Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Injeq Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Centre for Economic Development, Transport and the Environment Government Minority
Finnish Business Angels Network Not-For-Profit Venture Capital Minority
Finnvera Lender/Debt Provider Minority
Tesi Limited Partner Minority
To view Injeq’s complete investors history, request access »

Ready to get started?

Request a free trial

Injeq FAQs

  • When was Injeq founded?

    Injeq was founded in 2010.

  • Where is Injeq headquartered?

    Injeq is headquartered in Tampere, Finland.

  • What is the size of Injeq?

    Injeq has 16 total employees.

  • What industry is Injeq in?

    Injeq’s primary industry is Medical Supplies.

  • Is Injeq a private or public company?

    Injeq is a Private company.

  • What is Injeq’s current revenue?

    The current revenue for Injeq is .

  • How much funding has Injeq raised over time?

    Injeq has raised $10.5M.

  • Who are Injeq’s investors?

    Centre for Economic Development, Transport and the Environment, Finnish Business Angels Network, Finnvera, and Tesi have invested in Injeq.

  • Who are Injeq’s competitors?

    Novosanis, NanoPass Technologies, Current Surgical, and PharmaJet are competitors of Injeq.

  • When was Injeq acquired?

    Injeq was acquired on 25-Sep-2024.

  • Who acquired Injeq?

    Injeq was acquired by Flat Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »